January 22, 2018
Mochida Pharmaceutical won approval for its biosimilar version of Pfizer’s Enbrel (etanercept) on January 19, with rheumatoid arthritis (RA) specialty firm Ayumi Pharmaceutical responsible for its marketing and distribution. The biosimilar version, which has been developed in Japan by Mochida...read more